Cost-Utility Analysis of Telaprevir in Combination with Peginterferon Alpha and Ribavirin in Previously Untreated Patients with Chronic Hepatitis in a Romanian Setting

Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1125
https://www.valueinhealthjournal.com/article/S1098-3015(13)03030-1/fulltext
Title : Cost-Utility Analysis of Telaprevir in Combination with Peginterferon Alpha and Ribavirin in Previously Untreated Patients with Chronic Hepatitis in a Romanian Setting
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03030-1&doi=10.1016/j.jval.2013.08.1125
First page : A499
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 978
Categories :
Tags :
Regions :
ViH Article Tags :